The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.
William Tran
Advertisement
William Tran is a senior scientist at Biologics Process R&D, Merck and Co. (MSD outside of the United States and Canada).
Articles by William Tran
Advertisement
Latest Updated Articles
Right the First Time: Bioreactor Scale and Design TranslationJanuary 1st 2024
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
4
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
5